Sage Mountain Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $625K | Buy |
1,405
+163
| +13% | +$72.6K | 0.04% | 205 |
|
|
2025
Q1 | $602K | Sell |
1,242
-63
| -5% | -$30.5K | 0.04% | 191 |
|
|
2024
Q4 | $526K | Buy |
1,305
+146
| +13% | +$58.8K | 0.04% | 201 |
|
|
2024
Q3 | $539K | Sell |
1,159
-3
| -0.3% | -$1.4K | 0.05% | 189 |
|
|
2024
Q2 | $545K | Buy |
1,162
+421
| +57% | +$197K | 0.05% | 168 |
|
|
2024
Q1 | $310K | Buy |
741
+63
| +9% | +$26.3K | 0.03% | 233 |
|
|
2023
Q4 | $276K | Buy |
678
+14
| +2% | +$5.7K | 0.03% | 217 |
|
|
2023
Q3 | $231K | Buy |
664
+45
| +7% | +$15.6K | 0.03% | 219 |
|
|
2023
Q2 | $218K | Buy |
+619
| New | +$218K | 0.03% | 236 |
|